Skip to main content

Table 2 Correlation between clinical score and disease progression (day 1–35).

From: Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease

 

Clinical score

 

Brain

Spinal cord

 

R

P

R

P

Astrogliosis (GFAP)

0.700

0.0001

0.817

< 0.0001

Microgliosis (CD68)

0.642

0.0007

0.803

< 0.0001

T cell infiltration (CD4)

0.784

< 0.0001

0.855

< 0.0001

Weight loss

R= 0.855; P= 0.0001

  1. GFAP-luc mice were immunized with MOG35–55 emulsified in CFA plus pertussis toxin. Mice were evaluated daily for clinical signs. Bioluminescence was recorded in living mice and expressed as fold induction over baseline measured 1 day before immunization. Neuroinflammation was measured by immunolabeling for GFAP (astrogliosis), CD68 (microgliosis) and CD4 (T cell infiltration). These markers were quantified separately in brain (cerebellum) and spinal cord using Metamorph image analysis software. The correlation between these markers and corresponding clinical score was assessed by Pearson correlation analysis (n = 23 mice). R: correlation coefficient.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094